USA v. Peizer
Case Number:
2:23-cr-00089
Court:
Nature of Suit:
Judge:
Firms
-
April 24, 2024
Bid To Sanction DOJ Denied In Novel Insider Trading Case
A California federal judge on Tuesday refused to grant an indicted former healthcare CEO's bid to sanction the government in a case accusing him of a novel form of insider trading, saying the CEO failed to show that he was prejudiced by the government interviewing a potential witness without counsel present.
-
April 22, 2024
Exec In Insider Trading Case Says Feds Denied Him Counsel
The former CEO at the center of a novel insider trading case is asking that the California jury deciding his fate not be allowed to hear evidence obtained during a pre-indictment interrogation, arguing he was denied access to an attorney despite insisting on speaking to counsel at least a dozen times.
-
April 02, 2024
Prosecutors Call Indicted Exec's Misconduct Claims 'Flawed'
Prosecutors have asked a California federal judge to reject a bid for sanctions by a former healthcare CEO indicted on novel insider trading charges, arguing that his claims related to a separate case are based on "flawed grounds."
-
March 26, 2024
Indicted Exec Wants Suit Tossed For Prosecutors' Misconduct
A former healthcare CEO indicted on novel insider trading charges is trying once again to have the case tossed from California federal court, this time accusing prosecutors of improperly contacting a represented party in a separate but related civil case, weeks after a previous attempt to duck the charges failed.
-
March 08, 2024
Judge Keeps Novel Insider Trading Indictment Alive
A California federal judge has refused to throw out a novel insider trading indictment against a former healthcare CEO, saying that the federal prosecutors provided sufficient information to sustain their allegations that the executive acted criminally by shedding millions of dollars worth of stock at the same time an important client relationship was nearing its end.
-
January 09, 2024
DOJ Can't 'Salvage' Novel Insider Trading Case, Exec Says
The former healthcare CEO at the center of a novel insider trading indictment has moved to dismiss the criminal charges against him, arguing prosecutors failed to allege that shareholders were kept in the dark about a faltering customer relationship while the executive prepared to sell off millions of dollars worth of stock.
-
March 06, 2023
DOJ Cautions Execs With Novel Insider Trading Case
An insider trading indictment against a CEO that the U.S. Department of Justice has hailed as "groundbreaking" may have meant to serve as a warning to executives leaning on so-called 10b5-1 trading plans to stay out of trouble, but it's unlikely to lead to a flood of similar prosecutions, experts told Law360.